Navigation Links
Sanarus Announces Partnership With Leading US Breast Care Physicians for the Next Generation Visica 2(TM) Treatment System for Fibroadenomas
Date:9/28/2007

NEW ORLEANS, Sept. 28 /PRNewswire/ -- Sanarus Medical today announced a partnership with leading breast care physicians from select centers across the country. These Centers, including breast care physicians from Connecticut to California, will work in partnership with Sanarus to increase the awareness and availability of an innovative, non-surgical treatment option for women with benign breast tumors, known as fibroadenomas. Sanarus will host a gathering of these new Centers prior to the American College of Surgeons (ACS) annual meeting in New Orleans.

In partnership with Sanarus, these centers will participate in regional and national efforts to increase patient and primary care physician awareness of the Visica 2 treatment as a minimally invasive, highly safe and effective treatment alternative to surgical excision. These Centers will participate in a patient registry to document the clinical outcomes and patient satisfaction rates following Visica 2 treatment.

Additionally, these Centers are dedicated to expanding private health insurance coverage of this important treatment option, making it more widely available to women across the country. Sanarus plans to include as many as 20 centers in this program before the end of 2007.

"I am very pleased to be a part of this important program that will offer more options to my patients. This technology makes cryoablation easier and faster than ever before and not only does that make sense for my practice, it makes the procedure very appealing to my patients," said Andrew Kenler, M.D., a surgeon from Connecticut and one of the newly created Visica 2 Reference Centers.

Visica 2 Treatment System

The original Visica(R) Treatment System received FDA market clearance in 2002 and has been proven highly safe and effective with more than 1,500 fibroadenomas treated. The innovative Visica 2 System has been available at select sites since April of 2007. The Visica 2 Treatment System uses liquid nitrogen as the freezing agent, obviating the need for large, high pressure tanks of argon and helium used in the original Visica Treatment System. Because nitrogen operates at colder temperatures than argon, it allows for a more efficient, faster treatment. The procedure can be completed in the physician's office, with most treatment times under 15 minutes. Early experience has shown excellent physician and patient satisfaction with the new Visica 2 Treatment System.

Sanarus will be demonstrating this ground breaking system at the American College of Surgeons (ACS) meeting, October 7-11 in New Orleans.

Sanarus Medical is based in Pleasanton, CA and is focused on providing patients and physicians with minimally invasive, office-based breast care management solutions from diagnosis and treatment to follow up. Using cryoablation technology, Sanarus has developed proprietary technologies to provide breast surgeons and radiologists with a comprehensive and minimally invasive way to diagnose and treat breast patients. The Sanarus technologies change the way that patients are managed, from an operating room-based, surgically intensive care pathway to a more comfortable, cost effective, office-based care pathway. Sanarus is dedicated to women's breast health and to providing minimally invasive solutions for the diagnosis and treatment of breast disease solutions that can help eliminate pain and improve quality of life. The company's website is http://www.sanarus.com.


'/>"/>
SOURCE Sanarus Medical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
Breaking Medicine Technology: